NeuroSigma Announces New Clinical Trial of Monarch eTNS
Trial to be conducted at UCLA and funded by a grant from National Institute on Alcohol Abuse and Alcoholism (NIAAA) First phase of trial will enroll up to 30 children ages 8 – 12 with exposure to alcohol during gestation to receive treatment with the Monarch Upon successful completion of Phase I, investigators will proceed … Read more